Assistant Professor @StanfordMed | Myeloma, Amyloidosis and Waldenstrom’s specialist | #CART #transplant | Proud 👩🎓: @MayoClinic @ClevelandClinic
Dec 7, 2020 • 4 tweets • 5 min read
1/ Key data presented #ASH20 from the FORTE, EMN02 and IFM-2009 trials further strengthen the role of transplant in myeloma. FORTE trial also provides key randomized data for dual maintenance. #mmsm#bmtsm Highlights below.
2/ Higher sustained MRD negativity and PFS benefit with KRD-ASCT vs KRD in the FORTE trial presented by Dr. Francesca Gay.
KR maintenance also leads to improved outcomes in all subgroups vs R maintenance alone. #mmsm#ASH20